Background: Idiosyncratic Drug Induced Liver Injury (DILI) is a rare adverse event to drugs that occasionally leads to severe liver damage, being one of the leading causes of Acute Liver Failure (ALF) in developed countries. DILI is largely a diagnosis of exclusion.
Discussion And Conclusion: Careful history of drug taking and ruling out other competing etiologies is mandatory given that DILI can present with an extremely variable phenotype. Several prognostic scores have been developed to promptly identify patients with potential risk of developing ALF. New biomarkers to diagnose and predict DILI evolution are under study and hopefully we will benefit from these novel tools in the near future.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/1574886314666190215115434 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!